deltatrials
Completed PHASE2/PHASE3 NCT00974766

Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis

Randomized Controlled Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions Allergic Bronchopulmonary Aspergillosis
Interventions Glucocorticoids
Updated 7 times since 2017 Last updated: Feb 22, 2015 Started: Apr 30, 2009 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This PHASE2/PHASE3 trial investigates Allergic Bronchopulmonary Aspergillosis and is currently completed. Post Graduate Institute of Medical Education and Research, Chandigarh leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. May 2024 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Apr 2024 — May 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2021 — Apr 2024 [monthly]

    Completed PHASE2_PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Post Graduate Institute of Medical Education and Research, Chandigarh
Data source: PIMERIndia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chandigarh, India